Top Banner
Copyright © 2012, Glenn Duncan Do not reproduce any workshop materials without express written consent. Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders Glenn Duncan LPC, LCADC, CCS, ACS
126

Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

May 07, 2015

Download

Health & Medicine

Glenn Duncan

Evidence Based Treatment in the consideration of treating anxiety and depressive disorders in the substance using populations. Introduction into these disorders, DSM-5 preview with changes to substance use disorders, certain anxiety and mood disorders. Cultural and best practices treatment considerations (Mindfulness, DBT, MI, Cognitive Behavioral Therapy are in focus with mentions on other best practices such as EMDR). Issues of duty to warn and protect are covered also.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Copyright © 2012, Glenn Duncan Do not reproduce any workshop materials without express written consent.

Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Glenn Duncan LPC, LCADC, CCS, ACS

Page 2: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Evidence Based Treatment Practices At the treatment level, interventions that have their own

evidence to support them as EBPs are frequently a part of a comprehensive and integrated response to persons with co-occurring disorder.

These interventions include: Psychopharmacological Interventions Motivational Interventions Cognitive/Behavioral Interventions Relaxation/Stress Inoculation Interventions Dialectical Behavior Therapy/Mindfulness Interventions

Page 3: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Evidence Based Treatment Practices At the program level, the following models have an evidence

base for producing positive clinical outcomes for persons with Co-occurring disorders:

Modified Therapeutic Communities - Individualized treatment, including lengths of stay tailored to the person's needs, is especially important due to the complexity of possible problems. In addition, TC clinical and management activities may need to be modified in terms of disciplinary sanctions, peer interactions, and degree of confrontation in groups. They also provide access to mental health and social services for individuals with co-occurring mental illness and substance abuse

Integrated Dual Diagnosis Treatment - This treatment approach helps people recover by offering both mental health and substance abuse services at the same time and in one setting.

Page 4: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Evidence Based Treatment Practices Assertive Community Treatment – ACT programs integrate behavioral

treatment for more severe mental health disorders such as schizophrenia. ACT emphasizes more intense outreach, highly individualized approaches to clients, and smaller caseloads.

Eye Movement Desensitization and Reprocessing – EMDR is a comprehensive, integrative psychotherapy approach. During treatment various procedures and protocols are used to address the entire clinical picture. One of the procedural elements is "dual stimulation" using either bilateral eye movements, tones or taps. EMDR has been recognized as being effective with Post Traumatic Stress Disorder. Only a licensed mental health professional can be trained in EMDR.

Cognitive Behavioral Therapy – CBT is designed to modify harmful beliefs and maladaptive behavior. CBT is the most effective form of therapy for anxiety and mood disorders. We will address CBT in more detail later in this presentation.

Page 5: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Evidence Based Treatment Practices Mindfulness – Mindfulness is the capacity to pay attention, non-

judgmentally, to the present moment. It helps individuals accept and tolerate the powerful emotions they may feel when challenging their habits or exposing themselves to upsetting situations.

Dialectical Behavior Therapy (DBT) – Originally devised by Marsha Linehan at the University of Washington in Seattle for the treatment of Borderline Personality Disorders, DBT combines standard cognitive-behavioral techniques for interpersonal effectiveness, emotion regulation and reality-testing with concepts of distress tolerance, acceptance, and mindfulness.

Motivational Interviewing (MI) – Motivational Interviewing is intended to resolve ambivalence and getting the client moving along the path to change. The goal of the first part of therapy is to build motivation for change. The assumption in this part of therapy is that the client is ambivalent, and in the contemplation or precontemplation stage.

Page 6: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP - Mindfulness

Mindfulness – Mindfulness is the capacity to pay attention, non-judgmentally, to the present moment.

Mindfulness is all about living in the moment, experiencing one's emotions and senses fully, yet with perspective.

It helps individuals accept and tolerate the powerful emotions they may feel when challenging their habits or exposing themselves to upsetting situations.

The concept of mindfulness and the meditative exercises used to teach it are derived from traditional Buddhist practice, and appears particularly useful in working with clients with either sub-acute anxiety or anxiety disorders.

Page 7: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Defining Mindfulness

Mindfulness has been defined as bringing one’s complete attention to the present experience on a moment-to-moment basis.

It has also been defined as paying attention in a particular way: on purpose, in the present moment, and nonjudgmentally, and involves a kind of non-elaborative, nonjudgmental, present-centered awareness in which each thought, feeling, or sensation that arises in one’s consciousness and is acknowledged and accepted as it is.

Bishop, Lau, et. al., offered a two-component model of mindfulness:

1. The first component [of mindfulness] involves the self-regulation of attention so that it is maintained on immediate experience, thereby allowing for increased recognition of mental events in the present moment.

2. The second component involves adopting a particular orientation toward one’s experiences in the present moment, an orientation that is characterized by curiosity, openness, and acceptance.

Page 8: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

What is Mindfulness?

Mindfulness includes the following qualities:

Non-judgmental awareness Alert yet relaxed consciousness Compassionate witnessing of experience Curiosity

Mindfulness supports and enhances:

Development of a witness stance Acceptance and tolerance of strong feelings Compassion for self and others Resilience (the ability to rebound from adversity) Relaxation Peace of mind

Page 9: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

What is Mindfulness – Witness Stance What exactly does developing a “witness stance” mean with mindfulness?

The Witness is the part of your mind that watches - that is aware of thinking. Since the Witness is beyond the ego, it is not caught up in judging and is thus content in any situation. Another name for the Witness is the Self, or the unconditioned mind.

Witnessing is the observation of thoughts, emotions and images. Make no attempt to change the thoughts or images in any way. Simply observe and label them. On their own, they will arise, have a certain duration, and then dissolve.

This part of your self that is observing and labeling the thinking and images. This is called the Witness Consciousness, or the energy of Mindfulness - and is the part of our mind that remains forever untouched by its contents - by the thoughts and images arising within it.

A traditional metaphor for this aspect of mind is that it is similar to the deepest part of an ocean - which remains calm, still & silent, even if at its surface, waves (of thinking, emotion, or sensation) are raging.

Page 10: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy Dialectical Behavior Therapy (DBT) – Originally devised by

Marsha Linehan at the University of Washington in Seattle for the treatment of Borderline Personality Disorders, DBT combines standard cognitive-behavioral techniques for interpersonal effectiveness, emotion regulation and reality-testing with concepts of distress tolerance, acceptance, and mindfulness.

DBT was developed initially to treat suicidality in adults with borderline personality disorder; however, it now is being used effectively in adolescents with similar self-harm behaviors as well as other co-occurring psychiatric illnesses such as depression and anxiety.

DBT is an empirically supported technique, meaning that it has been clinically tested for its effectiveness in adolescents and adults.

Page 11: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy Mindfulness is one of the core concepts behind all elements of

DBT. It is considered a foundation for the other skills taught in DBT, because it helps individuals accept and tolerate the powerful emotions they may feel when challenging their habits or exposing themselves to upsetting situations.

The concept of mindfulness and the meditative exercises used to teach it are derived from traditional Buddhist practice, though the version taught in DBT does not involve any religious or metaphysical concepts.

Within DBT it is the capacity to pay attention, non-judgmentally, to the present moment; about living in the moment, experiencing one's emotions and senses fully, yet with perspective.

Page 12: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

"What" skillsObserve - This is used to non-judgmentally observe one’s environment within or outside oneself. It is helpful in understanding what is going on in any given situation.

Describe - This is used to express what one has observed with the observe skill. It is to be used without judgmental statements. This helps with letting others know what you have observed.

Participate - This is used to become fully involved in the activity that one is doing. To be able to fully focus on what one is doing.

Page 13: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

"How" skillsNon-judgmentally - This is the action of describing the facts, and not thinking about what’s “good” or “bad”, “fair”, or “unfair.” These are judgments because this is how you feel about the situation but isn’t a factual description. Being non-judgmental helps to get your point across in an effective manner without adding a judgment that someone else might disagree with.

One-mindfully - This is used to focus on one thing. One-mindfully is helpful in keeping your mind from straying into emotion mind by a lack of focus.

Effectively - This is simply doing what works. It is a very broad-ranged skill and can be applied to any other skill to aid in being successful with said skill.

Page 14: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

Distress tolerance

Many current approaches to mental health treatment focus on changing a person’s thoughts, feelings and/or belief systems regarding distressing events and circumstances.

They have paid little attention to accepting, finding meaning for, and tolerating distress.

Dialectical behavior therapy emphasizes learning to bear pain skillfully.

The goal is to become capable of calmly recognizing negative situations and their impact, rather than becoming overwhelmed or hiding from them.

Page 15: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

Distress tolerance

Distract with ACCEPTS - This is a skill used to distract oneself temporarily from unpleasant emotions.

1. Activities - Use positive activities that you enjoy.2. Contribute - Help out others or your community.3. Comparisons - Compare yourself either to people that are less

fortunate or to how you used to be when you were in a worse state.4. Emotions (other) - cause yourself to feel something different by

provoking your sense of humor or happiness with corresponding activities.

5. Push away - Put your situation on the back-burner for a while. Put something else temporarily first in your mind.

6. Thoughts (other) - Force your mind to think about something else.7. Sensations (other) – Do something that has an intense feeling other

than what you are feeling, like a cold shower or eating a spicy food.

Page 16: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

Distress tolerance

Self-soothe - This is a skill in which one behaves in a comforting, nurturing, kind, and gentle way to oneself. You use it by doing something that is soothing to you. It is used in moments of distress or agitation.

IMPROVE the moment - This skill is used in moments of distress to help one relax. Imagery, Meaning, Prayer, Relaxation, One thing in the moment, Vacation (brief) - Take a break from it all for a short period of time, and Encouragement

Pros and cons - Think about the positive and negative things about not tolerating distress.

Page 17: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

Distress tolerance

Radical acceptance - Let go of fighting reality. Accept your situation for what it is.

Turning the mind - Turn your mind toward an acceptance stance. It should be used with radical acceptance.

Willingness vs. willfulness - Be willing and open to do what is effective. Let go of a willful stance which goes against acceptance. Keep your eye on the goal in front of you.

Page 18: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

Emotional Regulation

Dialectical behavior therapy skills for emotion regulation include:1. Identify and label emotions2. Identify obstacles to changing emotions3. Reduce vulnerability to emotion mind4. Increase positive emotional events5. Increase mindfulness to current emotions6. Take opposite action than that emotion that the situation

evoked7. Apply distress tolerance techniques

Other skills of emotional regulation include understanding the story of the emotion, addressing ineffective health habits, mastering one skill at a time, problem solving when emotions are justified and learning to observe and experience your emotion and let it go.

Page 19: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

Emotional Regulation

Dialectical behavior therapy skills for emotion regulation include:1. Identify and label emotions2. Identify obstacles to changing emotions3. Reduce vulnerability to emotion mind4. Increase positive emotional events5. Increase mindfulness to current emotions6. Take opposite action than that emotion that the situation

evoked7. Apply distress tolerance techniques

Other skills of emotional regulation include understanding the story of the emotion, addressing ineffective health habits, mastering one skill at a time, problem solving when emotions are justified and learning to observe and experience your emotion and let it go.

Page 20: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

EBTP – Dialectical Behavior Therapy

Interpersonal Effectiveness

Interpersonal response patterns taught in DBT skills training are very similar to those taught in many assertiveness and interpersonal problem-solving classes. They include effective strategies for asking for what one needs, saying no, and coping with interpersonal conflict.

Interpersonal effectiveness focuses on situations where the objective is to change something (e.g., requesting that someone do something) or to resist changes someone else is trying to make (e.g., saying no).

The skills taught are intended to maximize the chances that a person’s goals in a specific situation will be met, while at the same time not damaging either the relationship or the person’s self-respect.

Skills including helping people get what they want when asking; aiding clients in maintaining his or her relationships, whether they are with friends, coworkers, family, romantic partners, etc.; and aiding oneself in maintaining their own self respect.

Page 21: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

21

EBTP – Motivational Interviewing

1. Assess Motivation, which consists of the following:- Importance – the extent to which one wants, desires, or wills change.- Readiness – what is the priority level of the presenting problem(s).- Confidence – self-efficacy, or the perceived ability to make a change.

2. Ask open ended questions to the client in response to their answers during the assessment period.- (e.g., “What are some other ways marijuana has interfered with other areas that are important to you?” versus “Is marijuana a problem for you?”)

3. Respond Reflectively (examples):- “It sounds like you are saying …”- “The way you see your drinking is …”- “From your point of view, the good part about using marijuana is …”

Page 22: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

22

MI - Stages of Readiness for Change

Precontemplation – The client is not ready to change and identification with the “problem” is marked with positive associations. Goal is to get client to form some ambivalence regarding problem.

Contemplation – Ambivalence exists with the client regarding problem (the association with the identified problem are now good and bad). Goal is to move the client into preparation stage.

Preparation – Client has substantially resolved ambivalence and prepares to commit to a change in the problem behavior. Goal is to move the client into the action stage.

Page 23: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

23

MI - Stages of Readiness for Change

Action – The client has committed to specific actions intended to bring about change, but needs help in maintaining this level of change. Goal is to provide client with help in this area and work client towards next stage.

Maintenance – The client enters the point of being able to sustain the changes accomplished previously. Replacing problem behaviors with new, healthy life-style.

Termination – Person exits the cycle of change without fear of relapsing to previous behavior. Much debate over whether certain problems can be terminated. (Termination needs the following: a new self image; no temptation in any situation; solid self-efficacy; and a healthier lifestyle)

Relapse/Recycling – Relapse to one of the first three stages of change. Expectable setbacks and hopefully learn from relapse before committing to a new cycle of action. Multidimensional assessment to explore relapse reasons.

Page 24: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

24

Principles of Motivational Interviewing

The strategies of Motivational Interviewing are more persuasive than coercive, more supportive than argumentative.

The counselor seeks to create a positive atmosphere that is conducive to change.

The overall goal is to increase the client’s intrinsic motivation, so that change arises from within, rather than being imposed from without.

There are 5 general principles underlying motivational interviewing:1. Express empathy2. Develop discrepancy3. Avoid Argumentation4. Roll with resistance5. Support self-efficacy

Page 25: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

25

Principle – Express Empathy

Empathy is NOT an ability to identify with a person’s experiences.

Empathy is a learnable skill for understanding another’s meaning through reflective listening, whether or not you’ve had similar experiences yourself. This is done without judging, criticizing or blaming … but with acceptance.

Empathic listening requires sharp attention to each new client statement, and a continual generation of hypotheses as to the underlying meaning.

Your interpretation as to the meaning is reflected back to the client, often adding to the content that was overtly stated.

Page 26: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

26

Principle – Develop Discrepancy

Create and amplify, in the client’s mind, a discrepancy between present behavior and broader goals.

Motivation for change is created when people perceive a discrepancy between their present behavior and important personal goals.

ME Therapist wants to develop discrepancy, make use of it, increase it, and amplify it until the discrepancy overrides attachment to the present behavior.

This change needs to occur within the client (not external forces), the client should present the arguments for change.

Page 27: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

27

Principle – Avoid Argumentation

A key principle to MET is to avoid arguments and head-to-head confrontations.

One place that arguments are very likely to emerge is in regard to the applicability of a diagnostic label. Some counselors place great importance on a client’s willingness to “admit” to a label such as “alcoholic”.

AA the emphasis is more on self-recognition. “We do not like to pronounce any individual as alcoholic, but you can quickly diagnose yourself.” (Bill W.)

Resistance is a signal for the therapist to change strategies.

Page 28: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

28

Principle - Roll with Resistance

Reluctance and ambivalence are not opposed, but are acknowledged by the therapist to be natural and understandable.

The therapist does not impose new views or goals. Rather, the client is invited to consider new information and is offered new perspectives.

Rolling with resistance includes involving the client actively in the process of problem solving. The client is a valuable resource in finding the solution to their problems.

Page 29: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

29

Principle – Support Self-Efficacy

Self-efficacy is a person’s belief in his/her ability to carry out and succeed with a specific task.

General goal of MET is to increase the client’s perceptions of his/her capability to cope with obstacles and to succeed in change.

The client not only can, but must make this change for themselves.

There is hope in the range of alternative approaches available. Thus a person who has failed in the past, may not have found the right approach.

Page 30: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Co-Occurring Further Defined

In the substance abuse field specifically, co-occurring usually refers to the following conditions existing with a DSM-IV-TR substance abuse or dependence disorder.

Psychological illness

Criminality including Domestic Violence

Developmental Disabilities

Chronic illness (medical) - Many of the more conservative definitions of co-occurring disorders tend to shy away from this last category. - Conservative definitions tend to strictly apply mental health related disorders found in the DSM-IV-TR as the disorders (other than substance abuse/dependence) that define “co- occurring”.

Page 31: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

3 Epidemiological Models

In the first model, psychiatric disorders lead to the use of drugs, which then can lead to abuse or dependence usage.

It may be that adverse parental factors are risk factors for both psychiatric disorders and drug use.

Many researchers have shown that those diagnosed with depression are particularly vulnerable to drug abuse. Depressive symptoms have been found to be associated with later drug use.

Conduct disorders/Oppositional Defiant Disorders have also been found to increase the risk of drug use in both earlier and later adolescence.

Page 32: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

3 Epidemiological Models

The second possible model postulates that psychiatric disorders and drug use are correlated because both conditions share common etiological factors. Thus both problems are caused by these factors and not related to the onset of the occurrence of one or the other.

Predisposing biological or genetic vulnerabilities, brain deficits, disorders of neurotransmitter functioning or metabolism.

Psychosocial factors include risks from the broad socio-cultural context or from peer, family, and personality domains. For example early exposure to stress or trauma.

Page 33: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

3 Epidemiological Models

A third possible model would be that drug use leads to certain psychiatric disorders, perhaps as a result of the psychopharmacological or toxic effects of drugs of abuse on brain functioning or metabolism, or drug effects on psychological functioning.

Drugs of abuse can cause abusers to experience one or more symptoms of another mental illness. Though research is more sparse on this etiological theory, the premise is that some latent, or subclinical symptomatology can be exacerbated by drug use, causing the once subclinical features to take on clinical feature even though the drug use has decreased/stopped.

Page 34: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Defining Differential Diagnosis

"Differential diagnosis" is the method by which a clinician determines what [DSM-IV-TR] disorder caused a client's symptoms.

The clinician considers all relevant potential causes of the symptoms and then eliminates alternative causes based on a clinical interview, use of standardized assessment tool(s) that provide a DSM-IV-TR diagnosis, and a thorough case history using corroborative information from significant people in the client’s life.

Thus differential diagnosis is the determination of which of two or more disorders with similar symptoms is the one from which the client is suffering, by a systematic comparison and contrasting of the clinical findings.

Page 35: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Differential Diagnosis as Used by the DSM The DSM has a section for each disorder, or at times class of

disorders (e.g., substance intoxication, covering a group of substances) which they entitle “Differential Diagnosis”.

In this section they discuss the disorder, or class of disorders, being discussed and how they are distinguished behaviors that are NOT classified as disorders. For example:

“Substance-Related Disorders are distinguished from non-pathological substance use (e.g., “social” drinking) and from the use of medications for appropriate medical purposes by the presence of a pattern of multiple symptoms occurring over an extended period of time (e.g., tolerance, withdrawal, compulsive use) or the presence of substance-related problems (e.g., medical complications, disruption in social and family relationships, vocational or financial difficulties, legal problems). Repeated episodes of Substance Intoxication are almost invariably prominent features of Substance Abuse or Dependence. However, one or more episodes of Intoxication alone are not sufficient for a diagnosis of either Substance Dependence or Abuse.”

Page 36: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Differential Diagnosis as Used by the DSM

Differential Diagnosis (continued):

In this section they can also discuss the disorder, or class of disorders, being discussed and how they ARE distinguished from other disorders (of the same class) in the DSM. For example in discussing the differential diagnosis of substance intoxication:

“It may sometimes be difficult to distinguish between Substance Intoxication and Substance Withdrawal. If a symptom arises during the time of dosing and then gradually abates after dosing stops, it is likely to be part of Intoxication. If the symptom arises after stopping the substance , or reducing its use, it is likely to be part of Withdrawal.”

Page 37: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Differential Diagnosis as Used by the DSM

Differential Diagnosis (continued):

Finally, in this section they can discuss the disorder, or class of disorders, being discussed and how they ARE distinguished from other disorders, diseases or conditions outside of the DSM. For example:

“Many neurological (e.g., head injuries) or metabolic conditions produce symptoms that resemble, and are sometimes misattributed to, Intoxication or Withdrawal (e.g., fluctuating levels of consciousness, slurred speech, in-coordination). The symptoms of infectious diseases may also resemble Withdrawal from some substance (e.g., viral gastroenteritis [stomach flu] can be similar to Opioid Withdrawal). If the symptoms are judged to be a direct physiological consequence of a general medical condition, the appropriate Mental Disorder Due to a General Medical Condition should be diagnosed.”

Page 38: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Case – The Innkeeper

Andy, aged 34, was admitted to the hospital only an hour ago. He understands the questions put to him, but cannot quite hear some of them, and gives a rather absentminded impression. He states his name and age correctly …. Yet he does not know the doctors, calls them by the names of his acquaintances, and thinks he has been here for two or three days. He does not know the date. He moves about in his chair, looks around him a great deal, starts slightly several times, and keeps on playing with his hands. Suddenly he gets up, and begs to be allowed to play on the piano for a little.

He sits down again immediately, on persuasion by staff, but then wants to go home so he can tell his wife “something else that he has forgotten”. He gradually gets more and more excited, saying that his fate is sealed; he must leave the world now; they might telegraph to his wife that her husband is lying at the point of death.

Page 39: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Case – The Innkeeper

We learn, by questioning him, that he is going to be executed by electricity, and also that he will be shot. “The picture is not clearly painted,” hey says; “every moment someone stands now here, now there, waiting for me with a revolver. When I open my eyes, they vanish.” He says a stinking fluid has been injected into his head and between his toes, which was done by government agents. With this he looks eagerly at the window, where he sees houses and trees vanishing and reappearing. If you show him a speck on the floor, he tries to pick it up, thinking it is money. The clients mood is apprehensive. His head is flushed, pulse is rapid, yet weak to the touch. His face is bloated and his eyes are watery. His breath smells strongly of alcohol, and his hands tremble when he stretches them outward.

Page 40: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Case – The Innkeeper

Andy has drunk hard since the age of 13. He currently drank last approximately 1 hour before coming to the hospital. He reports that it now takes him seven or eight liters of wine to get him intoxicated. He stated that it used to take him ½ of that amount before getting the injection of stinking fluid. He has not worked for years due to his “condition”, and that his last work mission was top secret (which is why he was tortured by government agents wielding stinking fluid syringes). While noting that his hands were trembling currently, he reported “you should see me after a couple of days with no wine”, and “I never shook like this before the injections”. He then stated that it was great to be back at the Inn, his favorite watering hole. Though he readily complained about the lack of wine at the “Inn”.

Which disorder(s) do you think Andy is potentially suffering from? Using Differential Diagnosis which is the most likely diagnosis?

Page 41: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

What is “abnormal”?

Abnormal:

Statistically uncommon, maladaptive cognitions, affect, and/or behaviors that are at odds with social expectations and that result in distress or discomfort.

“What is defined as psychopathology are those characteristics that differ from the dominant culture’s definition of normalcy, and vary over time, and with culture.”

Page 42: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Clinically Significant (statistically uncommon)

2.5% - 5%

In psychological testing clinically significant is 2 standard deviations above the norm. For example, 130 I.Q., 70 on the MMPI-2. Thus for mental health/substance use disorders, we are looking at symptoms that are 2 standard deviations from the norm when making a diagnosis.

2.5% - 5%

Page 43: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

What constitutes a “mental disorder”?

DSM-IV-TR Definition of Mental Disorder:

1. Clinically significant behavioral or psychological syndrome or pattern that occurs in an individual.

2. This pattern is associated with present distress (e.g., a painful symptom) or disability (i.e., impairment in one or more important areas of functioning) or with a significantly increased risk of suffering death, pain, disability, or an important loss of freedom.

3. In addition, this syndrome or pattern must not be merely an acceptable and culturally sanctioned response to a particular event, for example, the death of a loved one. 

4. Whatever its original cause, it must currently be considered a manifestation of a behavioral, psychological, or biological dysfunction in the individual. 

5. Neither deviant behavior (e.g., political, religious, or sexual) nor conflicts that are primarily between individual and society are mental disorders unless the deviance or conflict is a symptom of a dysfunction in the individual, as described above. 

Page 44: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

What constitutes a “mental disorder”?

Proposed DSM-5 Definition of Mental Disorder:

A Mental Disorder is a health condition characterized by significant dysfunction in an individual’s cognitions, emotions, or behaviors that reflects a disturbance in the psychological, biological, or developmental processes underlying mental functioning.

Some disorders may not be diagnosable until they have caused clinically significant distress or impairment of performance.

A mental disorder is not merely an expectable or culturally sanctioned response to a specific event such as the death of a loved one.

Neither culturally deviant behavior (e.g., political, religious, or sexual) nor a conflict that is primarily between the individual and society is a mental disorder unless the deviance or conflict results from a dysfunction in the individual, as described above.

NOTE: The diagnosis of a mental disorder is not equivalent to a need for treatment. Need for treatment is a complex clinical decision that takes into consideration such factors as symptom severity, symptom salience (e.g., the presence of suicidal ideation), the patient’s distress (mental pain) associated with the symptom(s), disability related to the patient’s symptoms, and other factors (e.g., psychiatric symptoms complicating other illness).

Page 45: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Substance-Use & Addictive Disorders (DSM-5)

Substance-Use Disorder 

A.A problematic pattern of [substance] use leading to clinically significant impairment or distress.

B.Two (or more) of the following occurring within a 12-month period:

1. [Substance] is often taken in larger amounts or over a longer period than was intended

2. There is a persistent desire or unsuccessful effort to cut down or control [substance] use

3. A great deal of time is spent in activities necessary to obtain [substance] , use the substance, or recover from its effects

4. Recurrent [substance] use resulting in a failure to fulfill major role obligations at work, school, or home (e.g., repeated absences or poor work performance related to [substance] use; substance-related absences, suspensions, or expulsions from school; neglect of children or household)

5. Continued [substance] use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance

Page 46: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Substance-Use & Addictive Disorders (DSM-5)

Substance-Use Disorder (continued)

B.Two (or more) of the following occurring within a 12-month period:

6. Important social, occupational, or recreational activities are given up or reduced because of [substance] use

7. Recurrent [substance] use in situations in which it is physically hazardous (e.g., driving an automobile) or operating a machine when impaired by substance use

8. [Substance] use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance

9. Tolerance, as defined by either or both of the following:6. A need for markedly increased amounts of [substance] to

achieve intoxication or desired effect7. Markedly diminished effect with continued use of the

same amount of the substance(Note: Tolerance is not counted for those taking medications under medical supervision)

Page 47: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Substance-Use & Addictive Disorders (DSM-5)

Substance-Use Disorder (continued)

B.Two (or more) of the following occurring within a 12-month period:

10. Withdrawal, as manifested by either of the following:a. The characteristic withdrawal syndrome for [substance]

(refer to Criteria A and B of the criteria set for Withdrawal)

b. The same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms(Note: Withdrawal is not counted for those taking medications under medical supervision such as analgesics)

11. Craving or a strong desire or urge to use [substance]

Page 48: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Substance-Use & Addictive Disorders (DSM-5)

Substance-Use Disorder (continued)

The Severity of each Substance Use Disorder is based on: 0 criteria or 1 criterion: No diagnosis 2-3 criteria: Mild Substance Use Disorder 4-5 criteria: Moderate Substance Use Disorder 6 or more criteria: Severe Substance Use Disorder

Among adolescents, 2 or 3 criteria identify a group with severity of alcohol use disorder very close to that of adolescents with DSM-IV alcohol abuse, while 4 or more criteria identify a group with severity very close to that of DSM-IV dependence. Using criterion counts results in much more homogeneous groups than DSM-IV’s abuse and dependence groups.

In the empirical research among adults, the proposed cutoff points have been shown to yield similar prevalence and high concordance in relation to the combined DSM-IV substance abuse and dependence diagnoses. However, it is still unclear as to whether 4-5 or 6 or more constitute what used to be substance dependence in adults.

Page 49: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Substance-Use & Addictive Disorders (DSM-5)

Substance-Use Disorder (continued)

In a May 29, 2012 response to Washington Post article citing difficulties with these proposed changes, the APA responded with the following:

Regarding Dependence, Addiction and the Changes: Research shows that the symptoms of people with substance use problems do not fall neatly into two discrete disorders. Also, the term “dependence” is misleading; people often confuse that with “addiction” when in fact the tolerance and withdrawal patients experience are actually very normal responses to some prescribed medications that affect the central nervous system.

Regarding How the New System Reflects DSM’s Old Definition of Dependence - By contrast, the higher end of the substance use disorder spectrum would be more equivalent to the prior substance dependence disorder and entails a distinct syndrome that includes compulsive drug-seeking behavior, loss of control, craving, and marked decrease in social and occupational functioning. Revising and clarifying these criteria should alleviate some misunderstanding around these issues.

Page 50: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Substance-Use & Addictive Disorders (DSM-5)

Substance-Use Disorder (Legal Problems – OUT; Cravings – IN)

Craving is defined as a strong desire for a substance, usually a specific substance. It is a common clinical symptom, tending to be present on the severe end of the severity spectrum. It has been variously defined as a trait with a time component (present or recent past) or as a lifetime component (ever experienced in your life).

Brain imaging studies have demonstrated subjective craving precipitated by drug-related cues and correlated with increased activity (blood flow) and dopamine release (PET study) in specific parts of the brain reward system.

Recurrent substance-related legal problems (e.g., arrests for substance related disorderly conduct. DSM-5 aggregate research all indicate that the legal problems criterion has an extremely low prevalence relative to other criteria, and its removal from the diagnosis has very little effect on the prevalence of substance use disorders while adding little information to the diagnoses in the aggregate. 

Page 51: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Substance-Use & Addictive Disorders (DSM-5)

Substance-Use Disorder (Legal Problems – OUT; Cravings – IN)

Alcohol Use DisorderCannabis Use DisorderHallucinogen Use Disorder (which has subsumed Phencyclidine [PCP])Inhalant Use DisorderOpioid Use DisorderSedative/Hypnotic Use Disorder (changed from Sedative, Hypnotic or Anxiolytic Disorder)Stimulant Use Disorder (combining DSM-IV-TR’s Cocaine and Amphetamine Abuse and Dependence)Tobacco Use DisorderUnknown Substance Use DisorderGambling Disorder

There are no Caffeine Use or Internet Use Disorders in the DSM-5.

Page 52: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Synthetic Cathinones (aka “Bath Salts”) Effects Summary Sheet

Aggression Agitation Breathing difficulty Bruxism (grinding

teeth) Confusion Dizziness Extreme anxiety

sometimes progressing to violent behavior

Fits and delusions Hallucinations Headache

Hypertension (high blood pressure)

Increased alertness/awareness

Increased body temperature, chills, sweating

Insomnia Kidney pain Lack of appetite Liver failure Loss of bowel control Muscle spasms Muscle tenseness Vasoconstriction

(narrowing of the blood vessels)

Nausea, stomach cramps, and digestive problems

Nosebleeds Psychotic delusions Pupil dilation Renal failure Rhabdomyolysis

(release of muscle fiber contents [myoglobin] that could lead to kidney problems)

Severe paranoia Suicidal thoughts Tachycardia (rapid

heartbeat) Tinnitus

Page 53: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

The LIST … Substituted Cathinones

•DMEC•Methedrone•Ethedrone•3-MOMC•2-FMC•2-FEC•3-FMC•3-FEC•3-CMC•3-BMC•Flephedrone•4-FEC•Brephedrone•FMMC2,5-DMOMCbk-MDA2,3-MDMCMethyloneEthyloneBMDPbk-IMP4-Fluorobuphedrone4-Bromobuphedrone

•Cathinone•Methcathinone•Ethcathinone•Buphedrone•NEB•NEP•Pentedrone•Dimethylcathinone•Diethylpropion•Bupropion•Mephedrone•3-MMC•3-MEC•3-EMC•3-EEC•4-EMC•4-EEC•Benzedrone•4-MEC•N,N-DMMC•N,N-DEMC•EDMC•3,4-DMMC

4-MeMABP4-Me-NEB4-MethoxybuphedroneButyloneEutyloneBMDBbk-DMBDB5-Methylmethylone5-Methylethylone2-Methylbutylone5-MethylbutylonePentyloneMMPMEPbk-Methiopropamineα-Phthalimidopropiophenoneα-PPPα-PBP3-MPBPEPBPMOPBPO-2384α-PVP (O-2387)

4-MePPPMOPPPFPPPMPBPPyrovalerone (O-2371)MPHPMDPPPMDPBPMDPVFPVPO-2390O-2494Naphyrone (O-2482)α-PVT

Substituted cathinones, which include some stimulants and entactogens, are derivatives of cathinone. The derivatives may be produced by substitutions at four different locations of the cathinone molecule.

Page 54: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Bath Salts and the Zombie ApocalypseThe Anecdotal “Evidence” …

May 3, 2011. CHARLESTON, W.Va. – An Alum Creek man has been arrested after neighbors allegedly found him standing over the dead body of a boy’s stolen pet pygmy goat while wearing women's underwear. This was our trendsetter http://bit.ly/mr2xny.

May and June, 2012 – A veritable outbreak of Zombie type behaviors with people the media reported that were supposedly on bath salts (mostly in Florida … fill in your own thoughts on this):

1. Florida Man (Rudy Eugene) Eats 75% of Another Man’s Face2. NJ Man Flings His Own Intestines at Police Who Try to Arrest Him3. Man on Bath Salts Bites a Chunk of Person’s Face in Domestic Dispute4. Man on Bath Salts Threatens to Eat Police Who Try to Arrest Him

Of course the most infamous of these is link #1, where the mother actually talked to the press to announce that her now deceased son (they had to kill him as when the police tried to stop him from eating the other man he merely growled at them) “was no zombie” and his former girlfriend stated he was either drugged or possessed. Rudy Eugene was on marijuana only, not bath salts. He was also found to have no human flesh in his stomach. However, the lab only tested for 6 chemicals, and as we have seen there are more than 6 chemicals being used/labeled as “bath salts”.

It doesn’t help that Center for Disease Control has a permanent internet website dedicated to how to best handle a Zombie Apocalypse.

Page 55: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Not Zombies … Yet Bath Salts are deadly

More recent rash of bizarre and deadly bath salts incidents

June 18, 2012. Houston, Texas - A man was found in the middle of a busy street shouting incoherently at oncoming traffic that swerved to miss him. Police finally got him out of the traffic when he “displayed signs of excited delirium” before he stopped breathing. He was pronounced dead at the hospital and had bath salts on him.

June 15, 2012. Robinson, Illinois - A naked man grabs onto random car hood while naked and surfs car hood for 4 miles. The driver calls 911 and drives 4 miles to meet police who then arrested the man, who had vials purportedly containing bath salts on him. He was “hallucinating wildly” … as opposed to hallucinating modestly.

June 14, 2012. Miami, Florida - A naked woman punched and choked her 3 year old son before the son was rescued by onlookers. She then grabbed her dog and did the same before the police came and tasered. She died from cardiac arrest as a result of the tasering (and likely drugs).

Page 56: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Psychiatric Symptoms Associated with Synthetic Marijuana (Spice/K2) The cannabinoid-like chemicals were developed in research

laboratories, for example, to study neuronal receptors found in the body and brain.

One of these synthetic cannabinoids, JWH-018, was first made in 1995 for experimental purposes in the lab of Clemson University researcher John W. Huffman, PhD.

These synthetic cannabinoids have been associated with attempted suicides, and have been linked to such adverse effects as increased anxiety, panic attacks, heart palpitations, respiratory complications, aggression, mood swings, altered perception, and paranoia.

Page 57: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ambiguities, Counselor Bias, and the DSM The DSM-IV-TR discusses the use of clinical judgment and

makes the following statement: "exercise of clinical judgment may justify giving a certain diagnosis to an individual even though the clinical presentation falls just short of meeting the full criteria for the diagnosis as long as the symptoms present are persistent and severe” (p. xxxii). 

Counselors, therefore, have a great deal of diagnostic leeway in determining whether or not a diagnosis is given. Consequently, values, biases, theoretical orientation, social status, privilege, and power may influence diagnostic judgments.

Counselors are inculcated with the dominant culture’s values and beliefs about mental health and illness. Thus counselors acquire a unconscious ideology that may remain unquestioned in the practice of diagnosis.

The dominant group’s power obscures the relationship between dominance and subordination. The dominant ideology about normalcy and psychopathology becomes unconscious.

Page 58: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Cultural Competence Issues

Cultural Competence – counselors are encouraged to strive for cultural competence when working with clients. Cultural competence is a multidimensional phenomenon comprised

of scientific mindedness, dynamic sizing, and culture-specific skills.

1. Scientific mindedness The formation of hypotheses to be tested via data collection (i.e.,

assessment) during assessment and treatment rather than relying on counselor assumptions or beliefs.

2. Dynamic sizing Knowing when to generalize and be inclusive and knowing when to

individualize and be exclusive in working with clients. This skill refers to the knowing how to use information regarding the potential impact and importance of clients’ cultural background without stereotyping individual clients based on their cultural background.

3. Cultural Specific Skills Those skills counselors possess that are specific to particular

cultural backgrounds (e.g., knowledge of the impact prejudice may have on racially diverse clients, or the proper assessment )

Page 59: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Steps to Improve Cultural Competence

No matter what the client problem (addictions, anxiety, depression), the following are a set of steps all counselors can take to be more culturally competent.

1. Self-awareness of own cultural background and worldview (as well as an understanding that clients’ backgrounds and worldviews may differ from your own)

2. Assessment of client including degree of acculturation, cultural values.

3. Pre-therapy intervention that orients clients to expectations regarding therapy/program.

4. Hypothesizing and hypothesis testing.5. Attending to credibility of the treatment and therapist (e.g., do

clients believe treatment will be effective? Do they believe therapist can help them meet their goals?).

6. Understanding the nature of therapist discomfort in treating clients of different cultural backgrounds.

7. Understanding clients’ perspectives.8. Develop treatment plan collaboratively so it is not inconsistent with

cultural beliefs.9. Willingness to consult with those who have experience with clients

of a particular cultural background.

Page 60: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ethnicity vs. Organizational Culture Exercise

You have entered into an mental health/substance abuse outpatient treatment organization as the new director of outpatient/intensive outpatient substance abuse treatment services. This is a mid sized organization that specializes in 3 distinct departments: mental health services, substance abuse services, and a specialized case management department for working with HIV+ clients. This outpatient facility states that it does short-medium term outpatient care for clients. During your second week in the organization, you attend your first bi-weekly, interdepartmental group supervision meeting. In this meeting the head of the outpatient mental health department presents a case.

This is a case of a Colombian female in her 40’s who was referred for treatment due to depression. She had been in treatment for approximately 9 months, and shared some news with her therapist (the outpatient director, lets call her Melissa).

Page 61: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ethnicity vs. Organizational Culture Exercise

The news the client presented was the happy news (according to the client) that her daughter was pregnant. The client was ecstatic over the news and delighted in sharing with her therapist. The therapist asked pointed questions, such as asking what the daughter will do about her college career (she is a Sophomore). The client stated that the daughter would drop out and return “eventually”, but the important thing would be focusing on her child, not her own education. The therapist then asked if the daughter would need help in rearing the child, the client responded “oh it will be great, I’ll mother her, her mother will mother her, her aunt will mother her, the baby will be well taken care of.” One last question the therapist put forth was a question concerning the father of the child. The client stated the father was not involved, nor was it necessary to have a male in the picture. “The baby will be more than cared for by us all, and my oldest son (14) will be a male role model for the baby.”

Page 62: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ethnicity vs. Organizational Culture Exercise

The therapist Melissa then described how upset she was about this, and was at a loss as to how to convey to the client that while this is a blessed event, it is also a bit of a crisis given the fact that the daughter will drop out of school and no man is involved in the picture.

This therapist (the mental health outpatient director) is a white woman in her mid 50’s, and in the past 5 years made a career change from working in New York City in the fashion industry (making well into the 6 figures per year), to becoming a therapist. This fact alone makes you question her sanity, which you do so quietly to yourself, not daring to state it in the meeting. However, the thought did cross your mind to just skip this woman’s treatment “crisis” and make the meeting interesting by asking her the reason for making the switch.

The therapist then asked the team for guidance on how to best handle the situation. Thinking to yourself that this therapist was biased in her view of the client and not taking her culture into account when viewing the problem, you were sure others would give her this feedback. What ensued became a bizarre interaction of suggestions for the therapist to help “the client realize the crisis she was in” by other staff members. Not one other member suggested that this is not a crisis at all.

Page 63: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ethnicity vs. Organization Culture Exercise

You begin thinking to yourself how bizarre this set of transactions just was, though thinking to yourself how useful this could be in some future workshop exercise. Since nobody in the room seemed to be responding to reality, you decide to dissociate and let your mind continue to wander away from the content of the meeting and drift towards thoughts of the group makeup. Thinking first about the fact that you’re the only male member, to how one therapist’s hair has surely taken on the unintended tint of blue, and then finally drifting to remind yourself to again search the employment section of Star Ledger this Sunday. Suddenly, and quite rudely, you’re awakened from what appeared to you as a more useful pursuit of your mental energies, as the focus of the group has turned to you. The director has asked you specifically to give some feedback on this issue to the group.

1. What feedback do you give to the director? Give reasons why you decided to say what you said.

2. What organization cultural issues exist in this program (that we know of)? How do these issues impact our decision making for question 1?

Page 64: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Substance Use Disorders & Anxiety/Depression A powerful relationship exists between substance use

disorders and mood and anxiety symptoms/disorders.

Individuals with substance use disorders are nearly twice as likely to have a mood or anxiety disorder, and the inverse is also true.

Also, many clients with substance use disorders experience one or more symptoms of a mental disorder but do not meet diagnostic thresholds.

Page 65: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Addiction and Sub-Acute Anxiety

Symptoms and sensitivity to these symptoms occur along a continuum of intensity from mild to severe, but depart from anxiety disorders in 3 ways:

1. Pattern of avoidance2. Level of anticipation of re-experiencing anxiety or panic 3. Degree of impairment in performing normal daily routines and

responsibilities.

Increased anxiety symptoms and sensitivity in substance use disorders has been linked to:

1. Continued substance use while in treatment2. Poorer treatment retention3. Greater post-treatment substance use4. Greater relapse rate (even after prolonged periods of sobriety)5. More severe withdrawal symptoms6. Increases in cravings7. Greater risk for the development of anxiety disorders if

untreated

Page 66: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Addressing Anxiety In Addictions Tx. Addressing anxiety symptoms (interventions focused on

anxiety symptoms) in substance use disorder treatment can be enormously beneficial. It can help:

1. Decrease cravings2. Allow clients to develop more effective coping skills3. Clients will show improvements in affect tolerance and

emotional regulation4. Helps to decrease anxiety levels during substance use

treatment

Page 67: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Nature of Anxiety – Anxiety on the Continuum

Appropriate Anxiety – e.g., feeling nervous when wanting to impress somebody. Anxiety we all feel.

Anxiety Disorders – Enough symptoms to make a diagnosis and should only be treated by a licensed mental health professional.

Threatening Anxiety – the anxiety we feel when somebody in the car in front of us stops suddenly and we need to react quickly to avoid an accident.

Extreme Anxiety Symptoms – these are maladaptive anxiety symptoms, that occur but not enough to warrant a diagnosis. These are sub-acute and can also be treated by a trained addictions professional.

Page 68: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Components of Anxiety

Anxiety is comprised of at least three components: 1) physiological component; 2) thoughts or cognitive component; and 3) behavioral component.

Physiological component to perceived threat – these are the physical feelings in the body that occur when we perceive a situation as threatening:

1. Increased heart beat, sweating, ringing in the ears, shortness of breath, feelings of choking, blurred vision, headaches, chest pains, nausea, trembling, numbness, chills, hot flashes, muscle aches.

If any of these feelings occur during times when a client is not reporting anxiety, then a referral to a medical professional would be appropriate.

Notable differences between anxiety and panic attacks are that panic attacks are very time limited (peaking within 5-10 minutes) and are usually accompanied by fears of dying, losing control or going crazy.

Thoughts or cognitive responses to perceived threat – Thoughts can play a large role on the onset, maintenance, and worsening of anxiety.

1. Through our interpretations of situations (e.g., interpreting them as being threatening or dangerous), we influence the anxiety levels we experience.

Page 69: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Components of Anxiety

Behavioral component to perceived threat – experiencing anxiety can result in a wide range of behavioral responses. They can range from avoidance behaviors (fleeing a scene that causes anxiety, not hanging out with friends because of social anxiety), to behaviors that only occur when anxiety is present (biting nails, becoming fidgety)

1. By avoiding a situation that is a perceived threat, the person succeeds in avoiding the components of anxiety.

2. These avoidant safety behaviors help to maintain the anxiety.

3. When somebody avoids a situation, the deprive themselves of learning the situation may not have been as dangerous as they perceived it to be.

4. They also start to believe that the only way to escape unpleasant anxiety is to avoid the situation, or to experience the situation in an altered state (under the influence of substances).

Page 70: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

The Relationship between Substance Use Disorders and Anxiety Disorders

Substance use can increase anxiety – it is postulated that 3 factors increase anxiety vulnerability among substance users:

1. The physiological effects of drug/alcohol use. Some substances have clear anxiety-increasing properties that may produce chronic anxiety as a result of prolonged and/or heavy usage.

2. Craving – people may use drugs or alcohol to manage not only craving but the associated anxiety that comes with craving.

3. Withdrawal – anxiety, stress and irritability are among the most common withdrawal symptoms associated with a variety of substances.

Mutual Maintenance Model1. Anxiety can lead to substance use.2. Substance use and withdrawal can increase anxiety.3. Subsequently continued substance use occurs to manage

anxiety symptoms, which then can cause the very symptoms they are trying to manage, causing a circular, continuous feeding effect.

Page 71: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

DSM-5 Changes to Anxiety Disorders

Anxiety Disorders are being carved out into 3 categories.

Anxiety Disorders

1. Separation Anxiety Disorder2. Panic Disorder3. Agoraphobia4. Specific Phobia5. Social Anxiety Disorder (Social Phobia)6. Generalized Anxiety Disorder7. Substance-Induced Anxiety Disorder8. Anxiety Disorder Attributable to Another Medical Condition9. Anxiety Disorder Not Elsewhere ClassifiedPanic Attack

Page 72: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

DSM-5 Changes to Anxiety Disorders

Anxiety Disorders are being carved out into 3 categories.

Obsessive-Compulsive and Related Disorders

1. Obsessive-Compulsive Disorder2. Body Dysmorphic Disorder3. Hoarding Disorder4. Hair-Pulling Disorder (Trichotillomania)5. Skin Picking Disorder6. Substance-Induced Obsessive-Compulsive or Related Disorders7. Obsessive-Compulsive or Related Disorder Attributable to Another

Medical Condition8. Obsessive-Compulsive or Related Disorder Not Elsewhere Classified

While suggested (cough)anonymously(cough) in the last go-around of DSM-5 open comment period, Nose Picking Disorder did not make it.

Page 73: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

DSM-5 Changes to Anxiety Disorders

Anxiety Disorders are being carved out into 3 categories.

Trauma- and Stressor-Related Disorders

1. Reactive Attachment Disorder2. Disinhibited Social Engagement Disorder3. Acute Stress Disorder4. Posttraumatic Stress Disorder5. Adjustment Disorders (now placed in this category)6. Trauma- or Stressor- Related Disorder Not Elsewhere Classified

Page 74: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

PTSD – No longer an “anxiety disorder”

Posttraumatic Stress Disorder – The Shared Anxiety Symptoms   

Phenomenologically, PTSD shares a number of symptoms (especially from its Hyperarousal/D Criterion cluster) with other anxiety disorders such as insomnia, irritability, poor concentration, and startle reactions. PTSD avoidance behavior is similar to phobic and anxious avoidance.

Physiological arousal and dissociation (e.g., derealization and depersonalization) also occur in panic disorder.

Persistent intrusive thoughts or memories are commonly observed across anxiety disorders, including generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), panic disorder, and social Phobia.

Page 75: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

PTSD – No longer an “anxiety disorder”

Posttraumatic Stress Disorder – The Differentiation   PTSD is primarily a disorder of reactivity, along with specific and

social phobia, rather than a syndrome with a consistent alteration of the tonic/basal state, such as depression and GAD.

Furthermore, anxiety is present in most psychiatric disorders. It is not a particularly sensitive and specific index to posttraumatic reactions, normal or abnormal.

A number of symptoms observed in PTSD, such as numbing, alienation, and detachment, are frequent depressive symptoms, and can be responsible for the high co-morbidity between the two disorders.

Although there is overlap between other anxiety disorders and depression, as well, this pattern suggests that PTSD is more than simply an anxiety disorder.

Page 76: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (DSM-5 Proposed Criteria)

A. Exposure to actual or threatened a) death, b) serious injury, or c) sexual violation, in one or more of the following ways:

1. directly experiencing the traumatic event(s)  2. witnessing, in person, the traumatic event(s) as they

occurred to others3. learning that the traumatic event(s) occurred to a close

family member or close friend; cases of actual or threatened death must have been violent or accidental

4. experiencing repeated or extreme exposure to aversive details of the traumatic event(s) (e.g., first responders collecting human remains; police officers repeatedly exposed to details of child abuse); this does not apply to exposure through electronic media, television, movies, or pictures, unless this exposure is work-related.

Page 77: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (DSM-5 Proposed Criteria)

B. Presence of one or more of the following intrusion symptoms associated with the traumatic event(s), beginning after the traumatic event(s) occurred:

1. spontaneous or cued recurrent, involuntary, and intrusive distressing memories of the traumatic event(s) (Note: In children, repetitive play may occur in which themes or aspects of the traumatic event(s) are expressed.)

2. recurrent distressing dreams in which the content or affect of the dream is related to the event(s) (Note: In children, there may be frightening dreams without recognizable content. )

3. dissociative reactions (e.g., flashbacks) in which the individual feels or acts as if the traumatic event(s) are recurring (such reactions may occur on a continuum, with the most extreme expression being a complete loss of awareness of present surroundings. (Note: In children, trauma-specific reenactment may occur in play.)

4. intense or prolonged psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event(s)

5. marked physiological reactions to reminders of the traumatic event(s)

Page 78: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (DSM-5 Proposed Criteria)

C. Persistent avoidance of stimuli associated with the traumatic event(s), beginning after the traumatic event(s) occurred, as evidenced by avoidance or efforts to avoid one or more of the following:

1. distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s)

2. external reminders (i.e., people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings about, or that are closely associated with, the traumatic event(s)

Page 79: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (DSM-5 Proposed Criteria)

D. Negative alterations in cognitions and mood associated with the traumatic event(s), beginning or worsening after the traumatic event(s) occurred), as evidenced by two or more of the following:

1. inability to remember an important aspect of the traumatic event(s) (typically due to dissociative amnesia that is not due to head injury, alcohol, or drugs)

2. persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (e.g., “I am bad,” “No one can be trusted,” "The world is completely dangerous").  (Alternatively, this might be expressed as, e.g., “I’ve lost my soul forever,” or “My whole nervous system is permanently ruined”). 

3. persistent, distorted blame of self or others about the cause or consequences of the traumatic event(s)

4. persistent negative emotional state (e.g., fear, horror, anger, guilt, or shame)

5. markedly diminished interest or participation in significant activities6. feelings of detachment or estrangement from others7. persistent inability to experience positive emotions (e.g., unable to have

loving feelings, psychic numbing)

Page 80: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (DSM-5 Proposed Criteria)

E. Marked alterations in arousal and reactivity associated with the traumatic event(s), beginning or worsening after the traumatic event(s) occurred, as evidenced by two or more of the following:

1. irritable or aggressive behavior2. reckless or self-destructive behavior3. hypervigilance4. exaggerated startle response5. problems with concentration6. sleep disturbance (e.g., difficulty falling or staying asleep

or restless sleep)

Page 81: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (DSM-5 Proposed Criteria)

E. Marked alterations in arousal and reactivity associated with the traumatic event(s), beginning or worsening after the traumatic event(s) occurred, as evidenced by two or more of the following:

1. irritable or aggressive behavior2. reckless or self-destructive behavior3. hypervigilance4. exaggerated startle response5. problems with concentration6. sleep disturbance (e.g., difficulty falling or staying asleep or

restless sleepF. Duration of the disturbance (Criteria B, C, D, and E) is more than

1 month.G. The disturbance causes clinically significant distress or

impairment in social, occupational, or other important areas of functioning.

Page 82: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (DSM-5 Proposed Criteria)

H. The disturbance is not attributed to the direct physiological effects of a substance (e.g., medication, drugs, or alcohol) or another medical condition (e.g. traumatic brain injury).

Specify if: With Delayed Expression: if the diagnostic threshold is not

exceeded until at least 6 months after the event (although the onset and expression of some symptoms may be immediate).

  Subtype: Posttraumatic Stress Disorder in Preschool

Children

Subtype: Posttraumatic Stress Disorder – With Prominent Dissociative (Depersonalization/Derealization) Symptoms

Page 83: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (What did they change?)

Revision of Criterion A1 – to remove ambiguities and tighten the definition of “traumatic event”

Deletion of Criterion A2 – because it has no utility (“the person’s response involved fear, helplessness or horror”)

Slight revision to Criterion B B1 clarified to define “intrusive recollection” and eliminate depressive

rumination B2  slight changes make the criterion more applicable across cultures

B3 clarified to indicate that flashbacks are dissociative symptoms that occur on a continuum

Dividing DSM-IV Criterion C into two separate clusters (e.g., DSM-5 Criteria C and D) Thereby resulting in four, rather than three distinct diagnostic clusters.

Revising and adding diagnostic symptoms for Criterion D (Negative Cognitions and Mood)

Page 84: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS – PTSD (What did they change?)

D2 (DSM-IV “foreshortened future”) clarified & expanded to encompass exaggerated negative beliefs and expectations about the future

D3 (new symptom) –persistent distorted blame of self or others

D4 (new symptom) – persistent negative emotional state Revising and adding diagnostic symptoms for Criterion E (“Alterations in

Arousal and Reactivity”)

E1 – clarifying that this pertains to behavior (“irritable or aggressive”)

E2  (new symptom) = reckless or self-destructive behavior

Eliminating the Acute vs. Chronic specifier Addition of a Preschool Subtype Addition of a Dissociative Subtype.

Page 85: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Generalized Anxiety Disorder (DSM-IV-TR vs. DSM-5)

Page 86: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Generalized Anxiety Disorder (DSM-IV-TR vs. DSM-5)

Page 87: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Generalized Anxiety Disorder (DSM-IV-TR vs. DSM-5)

Page 88: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Generalized Anxiety Disorder (DSM-IV-TR vs. DSM-5)

Page 89: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

IN FOCUS: Generalized Anxiety Disorder (DSM-IV-TR vs. DSM-5)

G. The disturbance is not better accounted for by another mental disorder (e.g., anxiety about Panic Attacks in Panic Disorder, negative evaluation in Social Anxiety Disorder, contamination or other obsessions in Obsessive-Compulsive Disorder, separation from attachment figures in Separation Anxiety Disorder, reminders of traumatic events in Posttraumatic Stress Disorder, gaining weight in Anorexia Nervosa, physical complaints in Somatic Symptom Disorder, perceived appearance flaws in Body Dysmorphic Disorder, or having a serious illness in Illness Anxiety Disorder).

Page 90: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

“Depressive Symptoms” – below disorder threshold

The term “depressive symptoms” refers to symptoms experienced by people who, although failing to meet DSM-IV-TR diagnostic criteria for a mood disorder, experience sadness, depressed mood, or “the blues,” and one or more additional possible symptoms:

1. Loss of interest in most activities 2. Significant unintentional change in weight or appetite 3. Sleep disturbances 4. Decreased energy, chronic fatigue or tiredness, feeling exhausted 5. Feelings of excessive guilt 6. Feelings of low self-esteem, low self-confidence, or worthlessness 7. Feelings of despair or hopelessness (pervasive pessimism about the future) 8. Avoidance of normal familial and social contacts 9. Frequent agitation, restlessness 10. Psychologically or emotionally detached 11. Feelings of irritability or frustration 12. Decrease in activity, effectiveness, or productivity 13. Difficulty in thinking (poor concentration, poor memory, or indecisiveness) 14. Excessive or inappropriate worries 15. Being easily moved to tears 16. Anticipation of the worst 17. Thoughts of suicide

Page 91: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

“Depressive Symptoms” – below disorder threshold

For individuals experiencing depressive symptoms: 1. The symptoms might be more pervasive extending beyond an expected

time frame. 2. Some affects may feel too powerful to the individual and have to be blocked

or distorted. 3. While the affect expressed might feel “normal” or appropriate to the person,

others might consider the person to be emotionally over- or under reacting. 4. A person will get stuck in an emotion, such as fearful or sad and not be able

to shake it, or he or she may look to an outside influence, such as a drug, to change the mood.

5. There may be significant impairment in a life-functioning area, such as relationships or work performance.

6. There may be significant reduction in use of healthy coping styles, resulting in adaptive responses that limit choice or alienate others.

7. There might be a significant negative or pessimistic cognitive bias, resulting in a person seeing life through negative filters.

8. A person might not be able to consistently identify his or her mood or might label an affect in a way that seems confusing to others. For instance, a person may identify himself as scared when he seems sad to others.

Page 92: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Major Depressive Episode – DSM-5

A. Five (or more) of the following criteria have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Note: Do not include symptoms that are clearly due to a medical condition.

1. Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels sad, empty, or hopeless) or observation made by others (e.g., appears tearful). Note: In children and adolescents, can be irritable mood.

2. Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day (as indicated by either subjective account or observation)

3. Significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in a month), or decrease or increase in appetite nearly every day. Note: In children, consider failure to make expected weight gain

Page 93: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Major Depressive Episode – DSM-5

4. Insomnia or hypersomnia nearly every day5. Psychomotor agitation or retardation nearly every day

(observable by others, not merely subjective feelings of restlessness or being slowed down)

6. Fatigue or loss of energy nearly every day7. Feelings of worthlessness or excessive or inappropriate guilt

(which may be delusional) nearly every day (not merely self-reproach or guilt about being sick)

8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective account or as observed by others)

9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide

Page 94: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Major Depressive Episode – DSM-5

B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. (Language regarding “impairment” may change for consistency with DSM-IV conventions)

C. The episode is not attributable to the direct physiological effects of a substance or another medical condition

D. The Major Depressive Episode is not better accounted for by Schizoaffective Disorder and is not superimposed on Schizophrenia, Schizophreniform Disorder, Delusional Disorder, or Psychotic Disorder Not Elsewhere Classified.

E. There has never been a Manic Episode or a Hypomanic Episode.

Page 95: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Major Depressive Episode – DSM-5

Note: This is NOT a codeable disorder

Note: The normal and expected response to an event involving significant loss (e.g., bereavement, financial ruin, natural disaster), including feelings of intense sadness, rumination about the loss, insomnia, poor appetite and weight loss, may resemble a depressive episode.

The presence of symptoms such as feelings of worthlessness, suicidal ideas (as distinct from wanting to join a deceased loved one), psychomotor retardation, and severe impairment of overall function suggest the presence of a Major Depressive Episode in addition to the normal response to a significant loss.

Page 96: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

DSM-5 - Suicidal Behavior Disorder

A. The individual has initiated a behavior in the expectation that it would lead to the individual’s own death within the last 24 months.

B. The behavior did not meet criteria for non-suicidal self-injury - that is, it did not involve self-injury directed to the surface of the body undertaken to induce relief from a negative feeling/cognitive state or to achieve a positive mood state without risk of death. Having undertaken one or more acts of non-suicidal self-injury in the past is not incompatible with the diagnosis.

C. The “time of initiation” is the time when the self-initiated behavior was undertaken by the individual who receives the diagnosis. The term “suicide attempt” can, therefore, apply to individuals who initiated the behavior and survived because of the timely interruption by a third party (sometimes known as an interrupted suicide) or because the individual changed his or her intent and decided to seek help (sometimes known as an aborted suicide).

D. The act was not initiated during a confused or delirious state. However, attempts initiated during intoxication or while under the influence of a substance do not preclude this diagnosis.

E. The act was not undertaken solely for a political or religious objective.

Page 97: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Suicidal & Homicidal Ideation

One needs to check for past and current levels of suicidal and homicidal ideation, gestures, and/or attempts.

Ideations are thoughts, and can range from fleeting thoughts, to well thought out plans. Gestures are non life threatening attempts at hurting oneself or another (e.g., superficially cutting oneself on the wrist, but to the point where one’s life was never in danger). Attempts are potential life threatening actions taken by an individual towards oneself or another.

Means, intent, lethality are key components to this assessment.

Other important red flags include, but not limited to, severe losses in ones life, identification with someone who killed themselves/others, chronic illnesses, depressive disorders, giving away one’s possessions.

Page 98: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Debunking Common Suicide Myths

Some of the common myths about suicidality include: MYTH: Clients will not make a suicide attempt if they

promise the counselor to not harm themselves. FACT: A variety of circumstances can influence suicidal

behavior. A promise by a client not to harm himself may not apply when a client is confronted with a variety of environmental, interpersonal, and psychological stressors. A “commitment to treatment” plan is generally considered more useful than a “no-suicide pact”

MYTH: Talking about suicidal thoughts will put the idea in a client’s head and make the problem worse.

FACT: Most clients want to talk about their suicidal thoughts and plans with someone. Talking with a nonjudgmental, accepting person about suicide can offer relief.

Page 99: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Debunking Common Suicide Myths

Some of the common myths about suicidality include: MYTH: Changing a client’s perception of the events in her

life will change her suicidality. FACT: Events are only one variable in an individual’s

suicidality. Other variables include the individual’s interpersonal support system; psychological variables such as depressive symptoms, depressive illness, despair and emptiness; cultural values and influences regarding suicidal behavior; and access to a method for suicide

MYTH: A client is not at risk of suicide unless he can describe a plan.

FACT: People sometimes impulsively act on suicidal thoughts, without a well-defined plan

Page 100: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

What to do with clients re: Suicide

Some “do’s” for working with clients who have suicidal thoughts or plans include:

1. Seek the clinical support and input of supervisors, consultants, and treatment team members.

2. Obtain the informed consent of the client to consult with a supervisor, appropriate mental health professionals, and referral resources about the client’s care.

3. Listen to the client’s experience and feelings without judgment.

4. Encourage clients to talk about their suicidal ideation, whether plans have been considered or made, and whether a method (a gun or medication, for instance) is available. This is important information to have when you consult with a supervisor or mental health professional.

Page 101: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

What to do with clients re: Suicide

Some “do’s” for working with clients who have suicidal thoughts or plans include:

5. Don’t allow yourself to be sworn to secrecy about the client’s suicidal thoughts or intent.

6. Engage the client in participating in a plan of care to intervene with suicidal thoughts and/or behaviors.

7. If possible, involve the client’s family and significant others in supporting the client.

8. Have a clear understanding of the ethical, legal, and agency guidelines in working with clients who are suicidal.

Page 102: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Imminent Danger Defined

Imminent danger is a concept used to describe problems that can lead to dire consequences for the client (and others). Imminent danger is defined as the following 3 components:

1. A strong probability that certain behaviors (such as continued alcohol or drug use or continued self harm) will occur.

2. The potential for such behaviors to present a significant risk of serious adverse consequences to the individual and/or others.

3. The likelihood that such harmful events will occur in the near future.

Page 103: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

The Duty to Warn Case Name: Vitaly TARASOFF v. REGENTS OF UNIV OF CA., et.

al. Date, Location, Cite: 1976 CA. 131 Cal Rptr 14, 551 p2d 334.

CA Supreme Court: Prosenjit Poddar told student health he wanted to kill Tatiana Tarasoff. Psychologist told supervising psychiatrist, who told campus police, who checked & let Poddar go.

Poddar killed Tatiana. Parents sued for "failure to warn"- Trial Court said no duty existed, but CA Supreme Court cited Simenson v Swenson, ordered trial; heard twice, settled out:1. “Tarasoff #1” -"Privilege ends where public peril begins.“2. “Tarasoff #2” - Therapist has an obligation to use

reasonable care to protect potential victim. SUPER LAND MARK - created whole new cause for action, but

based on Simenson v Swenson because settled out of court.

Page 104: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ohio’s Duty to Warn Law

Section 2305.51(F) Duty to Protect – Ohio Revised Code

(F) "KNOWLEDGEABLE PERSON" means an individual who has reason to believe that a mental health client or patient has the intent and ability to carry out an explicit threat of inflicting imminent and serious physical harm to or causing the death of a clearly identifiable potential victim or victims and who is either an immediate family member of the client or patient or an individual who otherwise personally knows the client or patient.

(2) for the purpose of this section, in the case of a threat to a readily identifiable structure, "CLEARLY IDENTIFIABLE POTENTIAL VICTIM" includes any potential occupant of the structure.

Page 105: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ohio’s Duty to Warn LawSection 2305.51(B) Duty to Protect – Ohio Revised Code

A mental health professional or mental health organization may be held liable in damages in a civil action, or may be made subject to disciplinary action by an entity with licensing or other regulatory authority over the professional or organization, for serious physical harm or death resulting from failing to predict, warn of, or take precautions to provide protection from the violent behavior of a mental health client or patient,

Only if the client or patient or a knowledgeable person has communicated to the professional or organization an explicit threat of inflicting imminent and serious physical harm to or causing the death of one or more clearly identifiable potential victims;

The professional or organization has reason to believe that the client or patient has the intent and ability to carry out the threat, and;

The professional or organization fails to take one or more of the following actions in a timely manner:

Page 106: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ohio’s Duty to Warn LawOne or more of the following actions must be taken in timely if

a Duty to Warn and Protect exists: Section 2305.51(B)

1.Exercise any authority the professional or organization possesses to hospitalize the client or patient on an emergency basis pursuant to section 5122.10 of the revised code;2.Exercise any authority the professional or organization possesses to have the client or patient involuntarily or voluntarily hospitalized under chapter 5122. of the revised code;3.Establish and undertake a documented treatment plan that is reasonably calculated, according to appropriate standards of professional practice, to eliminate the possibility that the client or patient will carry out the threat, and, concurrent with establishing and undertaking the treatment plan, initiate arrangements for a second opinion risk assessment through a management consultation about the treatment plan with, in the case of a mental health organization, the clinical director of the organization, or, in the case of a mental health professional who is not acting as part of a mental health organization, any mental health professional who is licensed to engage in independent practice;

Page 107: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ohio’s Duty to Warn LawOne or more of the following actions must be taken in timely if

a Duty to Warn and Protect exists: Section 2305.51(B)

4.Communicate to a law enforcement agency with jurisdiction in the area where each potential victim resides, where a structure threatened by a mental health client or patient is located, or where the mental health client or patient resides, and if feasible, communicate to each potential victim or a potential victim's parent or guardian if the potential victim is a minor or has been adjudicated incompetent, all of the following information:

4. The nature of the threat;5. The identity of the mental health client or patient making the

threat;6. The identity of each potential victim of the threat.

Page 108: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ohio’s Duty to Warn LawAll of the following applies if one or more of section B is acted upon: Section 2305.51(C)

C. All of the following apply when a mental health professional or organization takes one or more of the actions set forth in divisions (b)(1) to (4) of this section:

1.The mental health professional or organization shall consider each of the alternatives set forth and shall document the reasons for choosing or rejecting each alternative.

2.The mental health professional or organization may give special consideration to those alternatives which, consistent with public safety, would least abridge the rights of the mental health client or patient established under the revised code, including the rights specified in sections 5122.27 to 5122.31 of the revised code.

Page 109: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Ohio’s Duty to Warn LawAll of the following applies if one or more of section B is acted upon: Section 2305.51(C)

3.The mental health professional or organization is not required to take an action that, in the exercise of reasonable professional judgment, would physically endanger the professional or organization, increase the danger to a potential victim, or increase the danger to the mental health client or patient.4.The mental health professional or organization is not liable in damages in a civil action, and shall not be made subject to disciplinary action by any entity with licensing or other regulatory authority over the professional or organization, for disclosing any confidential information about a mental health client or patient that is disclosed for the purpose of taking any of the actions.

3. The immunities from civil liability and disciplinary action conferred by this section are in addition to and not in limitation of any immunity conferred on a mental health professional or organization by any other section of the revised code or by judicial precedent.

4. This section does not affect the civil rights of a mental health client or patient under Ohio or federal law.

Page 110: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

42-CFR-Part 2 – Exceptions to Confidentiality

§ 2.22 Notice to patients of Federal confidentiality requirements.

The confidentiality of alcohol and drug abuse patient records maintained by this program is protected by Federal law and regulations. Generally, the program may not say to a person outside the program that a patient attends the program, or disclose any information identifying a patient as an alcohol or drug abuser Unless:

1) The patient consents in writing: 2) The disclosure is allowed by a court order; or 3) The disclosure is made to medical personnel in a medical emergency or to qualified

personnel for research, audit, or program evaluation. Violation of the Federal law and regulations by a program is a crime. Suspected violations may be reported to appropriate authorities in accordance with Federal regulations. Violation of the Federal law and regulations by a program is a crime. Suspected violations may be reported to appropriate authorities in accordance with Federal regulations. Federal law and regulations do not protect any information about a crime committed by a patient either at the program or against any person who works for the program or about any threat to commit such a crime. Federal laws and regulations do not protect any information about suspected child abuse or neglect from being reported under State law to appropriate State or local authorities.

Page 111: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

42-CFR-Part 2 – Exceptions to Confidentiality

§ 2.22 Notice to patients of Federal confidentiality requirements.

Federal law and regulations do not protect any information about a crime committed by a patient either at the program or against any person who works for the program or about any threat to commit such a crime. Federal laws and regulations do not protect any information about suspected child abuse or neglect from being reported under State law to appropriate State or local authorities.

§ 2.14 Minor patients (d)(2) The applicant's situation poses a substantial threat to the life or physical well being of the applicant or any other individual which may be reduced by communicating relevant facts to the minor's parent, guardian, or other person authorized under State law to act in the minor's behalf.

Page 112: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

42-CFR-Part 2 – Exceptions to Confidentiality

§ 2.63 Confidential communications. a)A court order under these regulations may authorize disclosure of confidential communications made by a patient to a program in the course of diagnosis, treatment, or referral for treatment only if:

1) The disclosure is necessary to protect against an existing threat to life or of serious bodily injury, including circumstances which constitute suspected child abuse and neglect and verbal threats against third parties;

2) The disclosure is necessary in connection with investigation or prosecution of an extremely serious crime, such as one which directly threatens loss of life or serious bodily injury, including homicide, rape, kidnapping, armed robbery, assault with a deadly weapon, or child abuse and neglect; or

3) The disclosure is in connection with litigation or an administrative proceeding in which the patient offers testimony or other evidence pertaining to the content of the confidential communications.

Page 113: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Duty to Warn Vignette

Paul is referred to your organization for domestic violence. The domestic violence was towards a girlfriend who was attempting to break up with him. Paul and the girlfriend have since broken up, and she has a restraining order against him (which he states he abides by). Both clinicians with experience with this type of client are full and cannot accept anymore clients. As the clinical director you decide to give this case to an intern, who is supervised by one of your master’s level clinicians. The intern is assigned the case and not much happens for a few months that you are aware of. One week in supervision, your clinician comes to you to inform you that a situation has happened with this client.

You come to find out that Paul has been increasingly making threatening statements towards other drivers on the road when he travels to work. He describes how he gets “infuriated” by other drivers who cut him off, or don’t move out of the fast lane when he is behind them. At first “altercations” were just gestures back and forth between he and the other driver at the time. However, in the past week he followed another driver all the way to that person’s job, and proceeded to fight him in the parking lot.

Page 114: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Duty to Warn Vignette

When asked if anybody was hurt, Paul replied that the other person was “a bit bloody” when Paul left him on the parking lot grounds. Paul confided to the intern that he has now started carrying a gun in the car. He at first played with the intern by stating the gun was there for his “protection”, but later hinted that it might “come in handy” on his way to work. When pressed, Paul stated that he would only wave the gun at a potential “highway offender” to scare him/her. He also stated he is licensed to carry the gun, and the gun is loaded. The final piece of information that the clinician tells you is the nature of the domestic violence towards the ex-girlfriend was Paul hitting this woman on the face with the barrel of a gun.

Paul has been diagnosed with Intermittent Explosive Disorder (DSM-IV-TR 314.32). Paul is employed full-time at Home Depot and works as the customer service manager for returns. Basically his job consists of being the returns and complaints manager at the Home Depot.

Page 115: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Duty to Warn Vignette Questions

1. What are your obligations, if any? If you find you have obligations, who are you obliged to warn?

2. Currently the only form of feedback on this case comes from self-report of the intern to the clinician supervising the intern. Is this sufficient?

3. Were there any problems in the supervisory process that was described in this example?

Page 116: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Integrated Treatment Approaches

Client-centered approach1. Clients experiencing symptoms of anxiety and depression in

different ways. For example, some experience more of the physiological symptoms of anxiety, and for others the perceived threat impacts cognitions the most.

2. Therefore, an important first step in the treatment of clients with co-occurring symptoms is a thorough assessment of the client’s struggle to ascertain the particular symptoms they experience. Client-centered approach.

Psychoeducation1. The next step is to provide the client with psychoeducation

regarding the components of the co-occurring disorders. For example, with anxiety a client could be educated on the following:a. The 3 components of anxiety (physical, cognitive,

behavioral).b. The normative nature of anxiety (scale from normal anxiety

reactions to anxiety disorders).c. The mutual maintenance model.

Page 117: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Integrated Treatment Approaches - CBT

Cognitive Behavioral Therapy Approach

Symptom Monitoring1. Clients can be encouraged to monitor their

anxiety/depressive feelings (e.g., negative self statements which lead to depression, monitoring anxiety provoking situations).

2. Utilize homework assignments such as SUDS (subjective units of distress – utilizing a 0 – 10 or 0 – 100 scale).

Identification of automatic thoughts1. Clients can be provided with psychoeducation on the

definition of automatic thoughts and the relationship between thoughts and emotions such as anxiety and depression.

Page 118: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Integrated Treatment Approaches - CBT

Classification of thought distortions1. Mind Reading – assuming you know what others are thinking about

you.2. Fortune Telling – predicting the future.3. Catastrophizing – assuming catastrophic consequences to current

or future events (e.g., I’ll die if this doesn’t go perfectly).4. All or Nothing – interpreting situations as belonging to one of two

categories with no “shades of grey”.5. Discounting the positive – minimizing positive outcomes (e.g., that

conversation only went well because she is being nice to me, I’m really incompetent).

6. Labeling – applying a label to yourself or to others (e.g., “I’m just a piece of garbage like my father said I would be”).

7. Overgeneralization – assuming negative outcomes of one specific incident apply to other similar situations (e.g., “I got a bad grade in this class, therefore I’ll likely fail the others too”).

8. Shoulds – rigid rules about how you or others must behave in particular situations; these thoughts often involve perceived catastrophic consequences if proscribed behaviors are not followed.

Page 119: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Integrated Treatment Approaches - CBT

Cognitive Restructuring – techniques that can be useful in helping clients restructure their maladaptive automatic thoughts.

Creating a dialogue between anxious/depressed self and coping self1. Similar in technique with addictions where a counselor asks a

client to create a dialogue between their “addicted mind” and their “rational mind”.

2. Anxious mind: “I am getting too nervous.”3. Coping mind: “I have been avoiding this class for so long,

shouldn’t I expect to be nervous.”

Developing a rational response to the maladaptive automatic thought.1. What is the evidence that the automatic thought is true? Not true?2. Is there an alternative explanation?3. What is the worst that could happen? Could I live through it?

What is the most realistic outcome? What is the best that could happen?

4. What’s the effect of believing the automatic though? What would be the affect of changing my thinking?

5. What should I do about it?6. If somebody else had this thought, what would I tell him/her?

Page 120: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Successful Termination Criteria

A. It is sometimes hard to determine if a client has met the criteria for termination, and here are some guidelines to help ascertain whether or not termination is appropriate.

1. Decrease in symptoms2. Decrease in symptoms over time (stable decrease for

at least 8 weeks)3. Decrease in functional impairment (in other areas such

as interpersonal relationships, occupational and/or educational functioning, eating and grooming habits, etc.)

4. Evidence that the symptom decrease is due to new skill use and not spontaneous remission.

5. Use of new skills especially in high risk situations.6. Sense of pride regarding the use of new skills.7. Carryover decrease in symptoms to other areas.

Page 121: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Bibliography

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.

Center for Substance Abuse Treatment (In Press). Treating sub-acute anxiety in early recovery (working title). Treatment Improvement Protocol (TIP) Series. Rockville, MD: Center for Substance Abuse and Mental Health Services Administration. (NOTE: Information in this PowerPoint regarding the treatment of sub-acute anxiety was obtained from this yet released TIPS book from August, 2010. This TIPS book is scheduled for publication in 2012-2013 and information obtained is subject to change in the finalized version.)

Center for Substance Abuse Treatment. (1999). Enhancing motivation for change in substance abuse treatment. Treatment Improvement Protocol (TIP) Series 35. (HHS Publication No. SMA 99-3354). Rockville, MD: Center for Substance Abuse and Mental Health Services Administration.

Center for Substance Abuse Treatment. (2005). Substance abuse treatment for persons with co-occurring disorders. Treatment Improvement Protocol (TIP) Series 42. (HHS Publication No. (SMA) 05-3992). Rockville, MD: Center for Substance Abuse and Mental Health Services Administration.

Center for Substance Abuse Treatment. (2008). Managing Depressive Symptoms in Substance Abuse Clients During Early Recovery. Treatment Improvement Protocol (TIP) Series 48. DHHS Publication No. (SMA) 08-4353. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Page 122: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Bibliography

Dual Diagnosis. http://www.nyu.edu/odae/dualdiagnosis.html

DSM5.org – Information regarding the changes in substance use disorders, anxiety disorders, and depressive disorders was obtained from the DSM5.org website on February 22, 2011. (NOTE: This information is not finalized and subject to change before scheduled publication in Spring, 2013.)

Freidman, M.J., Resick, P. A., Bryant, R.A., Strain, J., Horowitz, M. & Spiegel, D. (2011). Classification of trauma and stressor-related disorders in DSM-5. Depression and Anxiety, 28: 737-749.

Gelhorn H, Hartman C, Sakai J, Stallings M, Young S, Rhee SH, Corley R, Hewitt J, Hopfer C, Crowley T. 2008. Toward DSM-V: an Item Response Theory analysis of the diagnostic process for alcohol abuse and dependence in DSM-IV. J. Amer. Acad. Child Adol. Psychiatry 47, 1329-1339.

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P. Dufour, M. C., Compton, W. et. al. (2004). Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807-816.

Page 123: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Bibliography

Holmes, P., Georgescu, S. & Liles, W. (2005). Further delineating the applicability of acceptance and change to private responses: The example of dialectical behavior therapy. The Behavior Analyst Today, 7(3), 301-311

Jakobsons, L. J., Brown, J. S., Gordon, K. H., & Joiner, T. E. (2007). When are clients ready to terminate? Cognitive and Behavioral Practice, 14, 218-230.

Johnson, K., Mullin, J. L., Marshall, E. C., Bonn-Miller, M. O., & Zvolensky, M. J. (2010). Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. American Journal of Addictions, 19, 277-282.

Linehan, M. M. & Dimeff, L. (2001). Dialectical Behavior Therapy in a nutshell, The California Psychologist, 34, 10-13. http://www.dbtselfhelp.com/DBTinaNutshell.pdf

Malla, A. & Payne, J. (2005). First episode psychosis: Psychopathology, quality of life, and functional outcome. Schizophrenia Bulletin, 31(3), 650-677.

Page 124: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Bibliography

McLellan, T & Dembo, R. (1995). Screening and Assessment of Alcohol and Other Drug Abusing Adolescents. Treatment Improvement Protocol (TIP) Series. U.S. Department of Health, Rockville, MD.

Miller, W. R. & Rollnick, S. (1998). Motivational Interviewing. Guilford Press. New York, NY.

Moon, K. F. (2004) The History of Psychiatric Classification: From Ancient Egypt to Modern America. A Website composed for the History of Psychology, The University of Georgia [Online].

National Institute on Drug Abuse (2008). Comorbidity: Addiction and Other Mental Illnesses (Rep. No. NIH Publication Number 08-5771). Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health.

National Institute on Drug Abuse. (2008). Can therapeutic communities treat clients with special needs? [Online] http://www.nida.nih.gov/researchreports/therapeutic/Therapeutic4.html#specialneeds

Page 125: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Bibliography

Ohio Duty to Warn Law was taken from the following places: Ohio Government Website – LA Writer, noting the following sections of Ohio Law: http://codes.ohio.gov/oac/5122-3-12 http://codes.ohio.gov/orc/2305.51 with special consideration for licensed professionals to understand the following: http://codes.ohio.gov/orc/5122.10 http://codes.ohio.gov/orc/5122.27 http://codes.ohio.gov/orc/5122.31 http://codes.ohio.gov/orc/5122.301

Rudd, M. D. (2006). The Assessment and Management of Suicidality. Sarasota, FL: Professional Resource Press.

Rudd, M. D., Joiner, T., & Rajab, M. H. (2001). Treating Suicidal Behavior: An Effective, Time-Limited Approach. New York: The Guilford Press.

SAMHSA. (2007). Understanding evidenced based practices for co-occurring disorders. Overview Paper 5. [Online] http://download.ncadi.samhsa.gov/prevline/pdfs/SMA07-4278.pdf

Page 126: Treating Co-Occurring Mood & Anxiety Disorders with Substance Use Disorders

Bibliography

Scott R. Bishop, Mark Lau, Shauna Shapiro, Linda Carlson, Nicole D. Anderson, James Carmody, Zindel V. Segal, Susan Abbey, Michael Speca, Drew Velting & Gerald Devins (2004). "Mindfulness: A proposed operational definition". Clinical Psychology: Science & Practice 11 (3): 230–241.

Washington Post Rebuttal Article Regarding the Proposed Criteria for Substance Use Disorders. (2012). http://dsmfacts.org/issue-accuracy/apa-clarifies-washington-postkaiser-health-news-article-on-dsm-5s-proposed-criteria-for-substance-use-disorder/

Wikipedia: Dialectical Behavior Therapy. http://en.wikipedia.org/wiki/Dialectical_Behavior_Therapy

Information on synthetic cathinones (“Bath Salts”) came from this online article: http://www.hdap.org/mdpv.html and information on synthetic cannabinoids (“Spice/K2”) came from this online article: http://www.hdap.org/spice.html